DArecca James 内部人交易：近期 SEC Form 4 交易
过去 18 个月，DArecca James（CIK 1583903）在 2 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-08-05）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-05 | Prestige Consumer Healthcare Inc. (PBH) | 董事 | 买入 | 2,981 | $0 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 2,505 | $141,006 |
| 2026-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 买入 | 29,312 | $0 |
| 2026-05-05 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 655 | $38,815 |
| 2025-08-06 | Prestige Consumer Healthcare Inc. (PBH) | 董事 | 买入 | 2,094 | $0 |
| 2025-06-03 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 买入 | 12,221 | $0 |
| 2025-06-03 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 5,864 | $406,844 |
| 2025-05-20 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 买入 | 7,111 | $0 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 622 | $43,154 |
| 2025-05-19 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 1,246 | $87,606 |
| 2025-05-05 | HAEMONETICS CORP (HAE) | EVP, Chief Financial Officer | 卖出 | 654 | $41,758 |
来源：SEC Form 4 申报文件 · 截至 2026-08-05